50
Participants
Start Date
June 3, 2023
Primary Completion Date
March 15, 2027
Study Completion Date
March 15, 2027
Gemtuzumab ozogamicine - Cytarabine - Gilteritinib
See Arms description paragraph
RECRUITING
CHU d'Amiens, Amiens
NOT_YET_RECRUITING
CHU d'Angers, Angers
RECRUITING
CH Victor Dupouy, Argenteuil
NOT_YET_RECRUITING
Hôpital Avicenne, Bobigny
RECRUITING
CHU Bordeaux, Bordeaux
RECRUITING
CHU de Caen, Caen
RECRUITING
CHMS de Chambery, Chambéry
RECRUITING
HIA Percy, Clamart
RECRUITING
CHU Henri Mondor, Créteil
RECRUITING
CHU Limoges, Limoges
NOT_YET_RECRUITING
Centre Léon Bérard, Lyon
RECRUITING
Hôpital Lyon sud, Lyon
NOT_YET_RECRUITING
Hôpital la Timone Conception, Marseille
RECRUITING
CH de Meaux, Meaux
RECRUITING
CHRU Nancy, Nancy
RECRUITING
CHU Nantes, Nantes
RECRUITING
Centre Antoine Lacassagne, Nice
RECRUITING
Centre Hospitalier Universitaire de Nice, Nice
RECRUITING
CHR Orléans, Orléans
NOT_YET_RECRUITING
Hôpital de la Pitié Salpétrière, Paris
NOT_YET_RECRUITING
Hôpital Necker, Paris
NOT_YET_RECRUITING
Hôpital Saint Louis, Paris
RECRUITING
CHU Poitiers, Poitiers
RECRUITING
CH René Dubos, Pontoise
NOT_YET_RECRUITING
CHU Robert Debré, Reims
RECRUITING
CHU Pontchaillou, Rennes
RECRUITING
Centre Henri Becquerel, Rouen
RECRUITING
CHRU Bretonneau, Tours
RECRUITING
Centre Hospitalier de Versailles, Versailles
NOT_YET_RECRUITING
IGR, Villejuif
Collaborators (2)
Acute Leukemia French Association
OTHER
Astellas Pharma Inc
INDUSTRY
Pfizer
INDUSTRY
Centre Antoine Lacassagne
OTHER